Avalo Therapeutics (AVTX) Q3 2026 Earnings

30JulConfirmed
Q3 2025
Q4 2025
Q2 2026
Next
-2.19
-1.67
-1.15
-0.62

Details

Expected EPS
-0.624
Actual EPS
N/A
Surprise EPS
0.62
Surprise Percent
+100%

Description

Avalo Therapeutics (AVTX) will report earnings of for Q3 2026 on July 30, 2026.

0 Comments

Share your thoughts